|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 21, 2017 ) The Asia Pacific HIV Diagnostics Market was worth USD 565.19 million in 2016 and is estimated to be growing at a growth rate of 10.40%, to reach 926.91 million by 2021. The human immunodeficiency virus (HIV) can be described as a kind of retrovirus that causes (AIDS). HIV affects the immune cells and thus weakens immune system bringing about loss of ability to fight against the organisms that cause diseases.
View Full Report @ http://www.marketdataforecast.com/market-reports/asia-pacific-hiv-diagnostics-market-2148/
HIV infection has no cure however there are medicines which help to balance out or decrease this infection so it doesn't prompt to AIDS. HIV diagnostics market is developing at a significant rate because of increment in the HIV infected cases and developing awareness about the same. The current situation is like various POC/rapid tests are in clinical examination and advancement in the item pipelines of significant market members and therefore are relied upon to acquire regulatory approval in different local segments of the market. This general increment in the quantity of item offerings to the market space around the world, is required to drive the development of the HIV diagnostics industry in the forecast period.
Major factors driving the market are, and the foreseen improvement and commercialization of novel, the technological advancement in disease diagnostic tests, regulatory authorities approved POC as well as rapid CD4, p24 antigen and EID tests; it is expected of all the major regional market segments to witness a growth in the market demand over the given period. There is a need to increase in introducing easily accessible, efficient robust diagnostics tests.
Because of the financial resource constrained settings in a huge share of the disease affected regions it is as yet not feasible to perform the current, complex screening, staging and monitoring tests. This is either because of the absence of adequate testing labs or an absence of prepared clinical technicians capable of performing the tests. These limitations of laboratory based testing are a catalyst to the improvement of convenient and simple to execute point of care, rapid tests.
The Asia Pacific HIV Diagnostics Market is segmented on the basis of Product, End-User, Type, and geography. Based on product, market is segmented into Instruments, Consumables (Assays and Kits & Reagents, Other consumables), Software & Services. Based on Type, market is segmented into HIV-2 & Group O Diagnostic Tests, Antibody Tests, Viral Identification Tests, CD4 Testing, Early Infant Diagnostics, Viral load testing. Further on the basis of Antibody tests, the market is segmented into (HIV-1 Antibody Confirmatory Tests- Western Blot Test, Indirect immunofluorescence Assays(IFA), (HIV-1 Screening tests- Elisa/EIA, Rapid Tests, Home Access Dried blood spots), Line immunoassays(Cnf), Radio immunoprecipitation Assays(RIPA)). Based on HIV-2 & Group O Diagnostic Tests market is further dived into DBS Tests, Blood Antibody Tests, Line ImmunoAssay (HIV-2) and based on Viral Identification Tests, market is divided into Qualitative PCR Tests, p24 Antigen Test, Viral Culture. On the basis of geography, the Asia Pacific market is analysed under various regions namely India, China, South Korea, Japan, Australia. North America was followed by Asia pacific in terms of revenue. Asia Pacific is predicted to grow at a rapid pace in the coming few years, because of its high unmet demand in India and China.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-hiv-diagnostics-market-2148/request-sample
Major players in the market are Abbott Healthcare, Brsitol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Zyomyx Inc., Apogee Flow Systems, Mylan inc., PointCare Roche Diagnostics, Technologies Inc., Qiagen, Siemens Healthcare, and bioMerieux dominated HIV diagnostics market share in 2016.
Market Segmentation
1) Product
Introduction
Consumables
o Assays and Kits &Reagents
o Other Consumables
Instruments
Software & Services
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
2) Type
Introduction
Antibody Tests
HIV Screening Tests
Elisa
Rapid Tests
Home Access Dried Blood Spots
HIV-1 Antibody Confirmatory Tests
Western Blot Tests
Indirect Immunofluorescence Assays (IFA)
Line Immunoassays
Radio-Immunoprecipitation Assays
HIV-2 & Group O Diagnostic Tests
Blood Antibody Tests
DBS Tests
Line ImmunoAssay (HIV2)
Viral Identification Tests
P24 Antigen Test
Qualitative PCR Tests
Viral Culture
CD4 Testing
Viral Load testing
Early Infant Diagnostics
Y-o-Y Growth Analysis, By Type
Market Attractiveness Analysis, By Type
Market Share Analysis, By Type
3) End User
Introduction
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Inquire before Buying at http://www.marketdataforecast.com/market-reports/asia-pacific-hiv-diagnostics-market-2148/inquire
Reasons to buy Asia Pacific HIV Diagnostics Market Research Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
